09.05.2008TIME: 17:35:01
LAST
9,16 €
OPEN
9,15 €
CHANGE
+1,21%»
COMPANY PIPELINE NEWS INVESTOR RELATIONS   Search
  mission statement
  COMPANY
COMPANY
  ThromboGenics is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company has useds ... more »  
 
English
Nederlands
Annual report English
Nederlands
COMPANY
COMPANY
PIPELINE PIPELINE
  ThromboGenics has developed a strong pipeline of products for the treatment of a broad range of conditions related to the vasculature, including visual disorders, ... more »  
  foto2
COMPANY
NEWS & EVENTS PIPELINE
 

Apr 9, 2008

ThromboGenics announces that it has completed patient enrolment for its Phase II MITI IV study... more »

ThromboGenics kondigt de voltooiing aan van de patiëntenrekrutering voor zijn Fase II MITI IV studie... meer »

 
  All rights reserved © Thrombogenic 2006 Last update: May 5, 2008 Inspired by Echo
 
PIPELINE COMPANY Pipeline overview